Similarly, PLOD3 knockdown suppressed ccRCC malignancy by downregulating TWIST1 expression, thereby inhibiting β-catenin and AKT signaling pathways (40). The gene discussed is PLOD3; the disease is nonpapillary renal cell carcinoma.